MALVERN, Pa, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for ...
Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.
As of January 13 at 9:30:21 a.m. EST. Market Open.
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has been granted a U.S. patent for the use of its leading compound, buntanetap, ...
The browser you are using is no longer supported on this site. It is highly recommended that you use the latest versions of a supported browser in order to receive an optimal viewing experience.
House G.O.P. Floats Medicaid Cuts and More to Finance Trump’s Huge Agenda President Trump wants a massive tax cut and immigration crackdown bill. Republicans must decide what to cut to help pay ...
Ukrainian forces described a different kind of enemy, fighting with unfamiliar tactics and little option to retreat. By Marc Santora and Helene Cooper Rupert Murdoch’s News Group Newspapers ...
One in 12 children globally faces online sexual abuse: Lancet study Approximately one in 12 children worldwide experienced online sexual abuse in the past year, according to a study published in ...
The USDA’s National Institute of Food and Agriculture (NIFA) is investing $14 million to support food safety research, outreach and workforce training. The investment will fund research and ...